BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2320231)

  • 1. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes.
    Younger DS; Rowland LP; Latov N; Sherman W; Pesce M; Lange DJ; Trojaborg W; Miller JR; Lovelace RE; Hays AP
    Neurology; 1990 Apr; 40(4):595-9. PubMed ID: 2320231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis.
    Younger DS; Rowland LP; Latov N; Hays AP; Lange DJ; Sherman W; Inghirami G; Pesce MA; Knowles DM; Powers J
    Ann Neurol; 1991 Jan; 29(1):78-86. PubMed ID: 1996882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM paraproteinemia in a patient with primary lateral sclerosis.
    Desai J; Swash M
    Neuromuscul Disord; 1999 Jan; 9(1):38-40. PubMed ID: 10063834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron disease and paraproteinemia.
    Rudnicki S; Chad DA; Drachman DA; Smith TW; Anwer UE; Levitan N
    Neurology; 1987 Feb; 37(2):335-7. PubMed ID: 3808319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraproteinemia and motor neuron disease].
    Saito T; Irie S; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1146-8. PubMed ID: 1297563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aluminium in sporadic motor neuron disease.
    Sood K; Nag D; Chandra SV
    Indian J Med Res; 1990 Feb; 92():9-12. PubMed ID: 2347614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undetected IgM paraproteins on serum protein electrophoresis.
    Garrison CP; Deegan MJ; Conn RB
    Am J Clin Pathol; 1981 Apr; 75(4):553-7. PubMed ID: 7223718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.
    Fujita K; Honda M; Hayashi R; Ogawa K; Ando M; Yamauchi M; Nagata Y
    J Neurol Sci; 1998 Jun; 158(1):53-7. PubMed ID: 9667778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and classification of paraproteins by capillary immunofixation/subtraction.
    Bossuyt X; Bogaerts A; Schiettekatte G; Blanckaert N
    Clin Chem; 1998 Apr; 44(4):760-4. PubMed ID: 9554486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyotrophic lateral sclerosis with multiple myeloma].
    Masi MC; Gironelli L; Bonuccelli U; Cei G; Meucci G; Giraldi C
    Riv Neurol; 1990; 60(5):167-70. PubMed ID: 2100033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathy and motor neuron syndromes associated with plasma cell disease.
    Patten BM
    Acta Neurol Scand; 1984 Jul; 70(1):47-61. PubMed ID: 6475486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS and paraproteinemia.
    Tavolato B
    Neurology; 1991 Feb; 41(2 ( Pt 1)):331-2. PubMed ID: 1992391
    [No Abstract]   [Full Text] [Related]  

  • 15. Motor neurone disease: an immunological study.
    Tavolato BF; Licandro AC; Saia A
    Eur Neurol; 1975; 13(5):433-40. PubMed ID: 50947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of immunofixation electrophoresis for detecting IgM paraproteins in serum.
    Kahn SN; Bina M
    Clin Chem; 1988 Aug; 34(8):1633-5. PubMed ID: 3135960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuron disease and plasma cell dyscrasia.
    Shy ME; Rowland LP; Smith T; Trojaborg W; Latov N; Sherman W; Pesce MA; Lovelace RE; Osserman EF
    Neurology; 1986 Nov; 36(11):1429-36. PubMed ID: 3762961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis?
    Chełstowska B; Kuźma-Kozakiewicz M
    Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis!
    Giacopuzzi Grigoli E; Cinnante C; Doneddu PE; Calcagno N; Lenti S; Ciammola A; Maderna L; Ticozzi N; Castellani M; Beretta S; Rovaris M; Silani V; Verde F
    Neurol Sci; 2022 Dec; 43(12):6951-6954. PubMed ID: 36121546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H
    Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.